Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-23T20:25:16.717Z Has data issue: false hasContentIssue false
  • English
  • Français

Free Fatty Acids and Stroke From Atrial Fibrillation

Published online by Cambridge University Press:  02 December 2014

J. David Spence
J. David Spence*
Affiliation:
Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, University of Western Ontario London, Ontario, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 38 , Issue 6 , November 2011 , pp. 803
Copyright
Copyright © The Canadian Journal of Neurological 2011

References

1.Seo, W-K, Kim, J, Kim, YH, et al.Elevated free fatty acid is associated with cardioembolic stroke subtype. Can J Neurol Sci. 2011; 38(6):874–9.Google Scholar
2.Schurks, M, Glynn, RJ, Rist, PM, et al.Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010;341:c5702.Google Scholar
3.Soardo, G, Donnini, D, Domenis, L, et al. Oxidative stress is activated by free fatty acids in cultured human hepatocytes. Metab Syndr Relat Disord. 2011;ePub ahead of print May 11, 2011.Google Scholar
4.Pilgeram, L.Control of fibrinogen biosynthesis: role of the FFA/albumin ratio. Cardiovasc Eng. 2010;10:78–83.Google Scholar
5.Mutanen, M, Freese, R.Fats, lipids and blood coagulation. Curr Opin Lipidol. 2001;12:25–9.Google Scholar
6.Miller, GJ, Martin, JC, Webster, J, et al.Association between dietary fat intake and plasma factor VII coagulant activity-a predictor of cardiovascular mortality. Atherosclerosis. 1986;60:269–77.Google Scholar
7.Rigla, M, Wagner, AM, Borrell, M, et al.Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patients. Metabolism. 2006;55:1437–42.Google Scholar
8.Nordoy, A, Bonaa, KH, Sandset, PM, et al.Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia. Arterioscler Thromb Vasc Biol. 2000;20:259–65.Google Scholar
9.Poli, D, Antonucci, E, Cecchi, E, et al.Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. Stroke. 2005;36:2159–63.Google Scholar
10.Spence, JD.Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 2007;7:830–8.Google Scholar
11.Mozaffarian, D, Katan, MB, Ascherio, A, et al.Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601–13.CrossRefGoogle ScholarPubMed
12.Spence, JD, Jenkins, DJ, Davignon, J.Dietary cholesterol and egg yolks: not for patients at risk of vascular disease. Can J Cardiol. 2010;26:e336–e9.Google Scholar
13.Spence, JD.Secondary stroke prevention. Nat Rev Neurol. 2010;6:477–86.Google Scholar